The comparison of ramosetron with ramosetron plus dexamethasone for postoperative nausea and vomitting after laparoscopic cholecystectomy.
Phase of Trial: Phase III
Latest Information Update: 02 Sep 2016
At a glance
- Drugs Ramosetron (Primary) ; Dexamethasone
- Indications Postoperative nausea and vomiting
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 15 Feb 2012 Planned number of patients changed from 150 to 76 as reported by Clinical Research Information Service (CriS) - Republic of Korea record.
- 20 Jan 2012 New trial record